﻿<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.irs.gov/efile" returnVersion="2019v5.2">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2021-03-19T08:05:26-05:00</ReturnTs>
    <TaxPeriodEndDt>2020-05-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>420714325</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>RSM US LLP</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>2021 L STREET NW SUITE 400</AddressLine1Txt>
        <CityNm>WASHINGTON</CityNm>
        <StateAbbreviationCd>DC</StateAbbreviationCd>
        <ZIPCd>20036</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2019-06-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>237033369</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>PHARMACISTS RESEARCH AND EDUCATION FDTN</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>AMER</BusinessNameControlTxt>
      <PhoneNum>3016648612</PhoneNum>
      <USAddress>
        <AddressLine1Txt>4500 EAST-WEST HIGHWAY NO 900</AddressLine1Txt>
        <CityNm>BETHESDA</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20814</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>STEVEN RUBLOFF</PersonNm>
      <PersonTitleTxt>SECRETARY AND CEO</PersonTitleTxt>
      <PhoneNum>3016648612</PhoneNum>
      <SignatureDt>2021-03-19</SignatureDt>
      <DiscussWithPaidPreparerInd>1</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <PreparerPersonGrp>
      <PreparerPersonNm>ELIZABETH W HELLER</PreparerPersonNm>
      <PTIN>P00397829</PTIN>
      <PhoneNum>2022932200</PhoneNum>
    </PreparerPersonGrp>
    <TaxYr>2019</TaxYr>
    <BuildTS>2022-09-23 18:48:47Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="8">
    <IRS990 documentId="RetDoc1038000001" referenceDocumentId="RetDoc1044400001">
      <DoingBusinessAsName>
        <BusinessNameLine1Txt>ASHP FOUNDATION</BusinessNameLine1Txt>
      </DoingBusinessAsName>
      <PrincipalOfficerNm>STEVEN RUBLOFF</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>4500 EAST-WEST HIGHWAY NO 900</AddressLine1Txt>
        <CityNm>BETHESDA</CityNm>
        <StateAbbreviationCd>MD</StateAbbreviationCd>
        <ZIPCd>20814</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2943234</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>0</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.ASHPFOUNDATION.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1968</FormationYr>
      <LegalDomicileStateCd>MD</LegalDomicileStateCd>
      <ActivityOrMissionDesc>THE MISSION OF THE ASHP FOUNDATION IS TO SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>12</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>9</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>125</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <NetUnrelatedBusTxblIncmAmt>0</NetUnrelatedBusTxblIncmAmt>
      <PYContributionsGrantsAmt>1768602</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>928082</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>512137</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>1118585</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>483729</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>325684</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>0</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2764468</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2372351</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>476870</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>432880</CYGrantsAndSimilarPaidAmt>
      <PYBenefitsPaidToMembersAmt>0</PYBenefitsPaidToMembersAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>1411898</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>1503470</CYSalariesCompEmpBnftPaidAmt>
      <PYTotalProfFndrsngExpnsAmt>0</PYTotalProfFndrsngExpnsAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>747211</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>704553</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>649631</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2593321</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2585981</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>171147</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>-213630</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>10276086</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>9865167</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>854211</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>864752</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>9421875</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>9000415</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>OUR MISSION:SUPPORT ASHP BY ADVANCING THE PROFESSIONAL PRACTICE OF PHARMACISTS AND THE PHARMACY WORKFORCE BY FUNDING RESEARCH AND EDUCATION THAT IMPROVES HEALTH OUTCOMES THROUGH OPTIMAL, SAFE AND EFFECTIVE MEDICATION USE.OUR VISION:AS THE PHILANTHROPIC ARM OF ASHP, THE FOUNDATION SHARES ASHP'S VISION THAT MEDICATION USE WILL BE OPTIMAL, SAFE, AND EFFECTIVE FOR ALL PEOPLE ALL OF THE TIME.</MissionDesc>
      <SignificantNewProgramSrvcInd>0</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>0</SignificantChangeInd>
      <ExpenseAmt>920408</ExpenseAmt>
      <GrantAmt>194985</GrantAmt>
      <RevenueAmt>610795</RevenueAmt>
      <Desc>EXCELLENCE IN PHARMACY PRACTICE &amp; LEADERSHIP DEVELOPMENT: RECOGNIZE AND PROMOTE EFFORTS THAT FOSTER EXCELLENCE AND GROWTH OF HEALTH-SYSTEM PHARMACYASHP STUDENT LEADERSHIP AWARD THIS PROGRAM, FUNDED THROUGH THE DAVID A. ZILZ FUND, IS ADMINISTERED BY THE ASHP PHARMACY STUDENT FORUM IN COLLABORATION WITH THE ASHP FOUNDATION. NINE STUDENTS WHO DEMONSTRATE HIGH ACADEMIC ACHIEVEMENT, EXCEPTIONAL INTEREST IN HEALTH-SYSTEM PHARMACY PRACTICE, AND OUTSTANDING LEADERSHIP SKILLS WERE RECOGNIZED. RECIPIENTS WERE: CLASS OF 2020 - LEAH SELZNICK, VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF PHARMACY, FALLS CHURCH, VA; JESSICA SHELLEY, OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHCLASS OF 2021 - UZO ABAJUE, TEXAS SOUTHERN UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCES, HOUSTON, TX; ALFRED AWUAH, UNIVERSITY OF GEORGIA COLLEGE OF PHARMACY, AUGUSTA, GA; AMY GUISINGER, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY-CHAPEL HILL, CHAPEL HILL, NC; MORGAN JONES, UNIVERSITY OF CINCINNATI JAMES L.WINKLE COLLEGE OF PHARMACY, CINCINNATI, OH; AMEE JOSHI, THE OHIO STATE UNIVERSITY COLLEGE OF PHARMACY, COLUMBUS, OH; KAVEH OLOUMI, MIDWESTERN UNIVERSITY COLLEGE OF PHARMACY-GLENDALE, GLENDALE, AZCLASS OF 2021 - ATHENA TRIGLIA,OHIO NORTHERN UNIVERSITY RAABE COLLEGE OF PHARMACY, ADA, OHTHE AWARDEES RECEIVED A PLAQUE, A $2,000 AWARD AND AN ASHP DRUG INFORMATION LIBRARY. EACH AWARDEE SUBMITTED A PLAN TO RAISE STUDENT AWARENESS OF THE ASHP PRACTICE ADVANCEMENT INITIATIVE. AWARDEES WILL BE SURVEYED TO COLLECT INFORMATION ON IMPLEMENTATION AND OUTCOMES OF THEIR PLAN.PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAMTHE 2019 PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM WAS SUPPORTED AGAIN BY AMGEN, INC. THIS UNIQUE AWARD RECOGNIZES EXCELLENCE AND LEADERSHIP IN THE TRAINING AND MENTORING OF PHARMACY RESIDENTS. THE PHARMACY RESIDENCY EXCELLENCE AWARDS PROGRAM RECOGNIZES A PRECEPTOR, NEW PRECEPTOR AND PROGRAM. THE OBJECTIVES OF THIS PROGRAM ARE TO: 1) RECOGNIZE THE ACHIEVEMENTS OF RESIDENCY PROGRAMS AND PHARMACISTS WHO HAVE DEMONSTRATED EXCELLENCE AND LEADERSHIP IN THE TRAINING OF PHARMACY RESIDENTS AND 2) WIDELY DISSEMINATE THE RESULTS OF THESE ACCOMPLISHMENTS TO FOSTER INNOVATIONS IN PHARMACY RESIDENT TRAINING. EACH AWARDEE WILL ALSO PRESENT AN EDUCATIONAL WEBINAR ON A RESIDENT PROFESSIONAL DEVELOPMENT TOPIC THAT CONTINUING EDUCATION CREDITS. THE WEBINARS ARE RECORDED AND MADE AVAILABLE FOR ON-DEMAND ACCESS. THE 2019 PROGRAM AND THE RECIPIENTS WERE:NEW PRECEPTOR: KATIE E. KORTE, PHARM.D., BCPS, BCCCP, TRUMAN MEDICAL CENTERS, KANSAS CITY, MOPRECEPTOR: JOEL C. MARRS, PHARM.D., BCPS, BCACP, BCCP, CLS, ASH-CHC, UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, AURORA, COPROGRAM: UNIVERSITY OF COLORADO SKAGGS SCHOOL OF PHARMACY, PGY2, AMBULATORY CARE, AURORA, COLITERATURE AWARDS PROGRAMTHE ASHP FOUNDATION LITERATURE AWARDS PROGRAM RECOGNIZES IMPORTANT CONTRIBUTIONS TO THE BIOMEDICAL LITERATURE BY PHARMACISTS. THIS PROGRAM, ADMINISTERED BY THE ASHP FOUNDATION SINCE 1971, IS BASED ON THE CONCEPT THAT RECOGNITION THROUGH AWARDS STIMULATES RESEARCH AND INNOVATION AND FOSTERS IMPROVEMENT IN THE QUALITY OF THE EVIDENCE. AWARDEES ARE RECOGNIZED AT THE ASHP MIDYEAR CLINICAL MEETING DURING THE SPOTLIGHT ON SCIENCE PLENARY SESSION. THE 2019 RECIPIENTS WERE: SUSTAINED CONTRIBUTIONSVINCENT H. TAM, PHARM.D., FIDA, BCPS, UNIVERSITY OF HOUSTONPHARMACY PRACTICE RESEARCH "IMPACT OF A PHARMACIST-PHYSICIAN COLLABORATIVE CARE MODEL ON PATIENT OUTCOMES AND HEALTH SERVICES UTILIZATION"AM J HEALTH SYST PHARM. 2018 75GARY R. MATZKE, B.S.PHARM., PHARM.D., LETICIA R. MOCZYGEMBA, PHARM.D., KAREN J. WILLIAMS, PHARM.D., MICHAEL J. CZAR, B.S.PHARM., PH.D., WILLIAM T. LEE, B.S.PHARM., M.P.A.INNOVATION IN PHARMACY PRACTICE"IMPACT OF REQUIRING RE-AUTHORIZATION OF RESTRICTED ANTIBIOTICS ON DAY 3 OF THERAPY"J ANTIMICROB CHEMOTHER. 2018; 73:KHALID ELJAALY, SALWA ELARABI, SAMAH ALSHEHRI, AND DAVID E. NIX DRUG THERAPY RESEARCH "ASSOCIATION OF INHALED CORTICOSTEROIDS AND LONG-ACTING MUSCARINIC ANTAGONISTS WITH ASTHMA CONTROL IN PATIENTS WITH UNCONTROLLED, PERSISTENT ASTHMA A SYSTEMATIC REVIEW AND META-ANALYSIS"JAMA. 2018;319DIANA M. SOBIERAJ, PHARMD; WILLIAM L. BAKER, PHARMD; ELAINE NGUYEN, PHARMD, MPH; ERIN R. WEEDA, PHARMD; CRAIG I. COLEMAN, PHARMD; C. MICHAEL WHITE, PHARMD; STEPHEN C. LAZARUS, MD; KATHRYN V. BLAKE, PHARMD; JASON E. LANG, MD, MPH STUDENT RESEARCH AWARD"PHARMACOTHERAPY-INDUCED HEPATITIS B REACTIVATION AMONG PATIENTS WITH PRIOR FUNCTIONAL CURE: A SYSTEMATIC REVIEW"ANNALS OF PHARMACOTHERAPY. 2019; 53. 2018;7RHIANNON M. BATH, BRANDELYN E. DOERING, MICHAEL D. NAILOR, PHARMD,, KELLIE J. GOODLET, PHARMDEDUCATION PROGRAMSTRAINEESHIPSIN FY20, THE FOUNDATION ADMINISTERED ONE TRAINEESHIP. PAIN AND PALLIATIVE CARE TRAINEESHIP THE PAIN AND PALLIATIVE CARE TRAINEESHIP INCLUDED ACCESS TO THE ASHP PAIN MANAGEMENT CERTIFICATE AND LIVE CASE-BASED WEBINARS, AN EXPERIENTIAL TRAINING COMPONENT, AND A POST-TRAINEESHIP PROJECT COMPONENT, WHICH WAS SUPPORTED THROUGH PARTICIPANT TUITION. IN FY20, 6 PHARMACISTS WERE ACCEPTED INTO THE TRAINEESHIP. DUE TO COVID19 RESTRICTIONS AND CONCERNS, THE DISTANCE EDUCATION WAS POSTPONED AND WILL BE SCHEDULED IN FY21. OTHER EDUCATIONAL PROGRAMSJOSEPH A. ODDIS COLLOQUIUMTHE COLLOQUIUM WAS ESTABLISHED TO PAY TRIBUTE TO ONE OF PHARMACY'S MOST DISTINGUISHED LEADERS AND ASSIST HEALTH-SYSTEM PHARMACISTS IN CONFRONTING ETHICAL CHALLENGES IN PHARMACY PRACTICE AND PATIENT CARE. THE 2019 COLLOQUIUM WAS OFFERED AS A LIVE EDUCATIONAL ACTIVITY PLANNED FOR THE 2019 ASHP SUMMER MEETINGS. PHARMACY RESIDENCY EXPANSION GRANTIN FY20, THE ASHP FOUNDATION, SUPPORTED BY EDUCATIONAL DONATIONS FROM ABBVIE AND MERCK, AWARDED $125,000 DOLLARS IN GRANTS TO PGY-1 AND PGY-2 PHARMACY RESIDENCY PROGRAMS TO INCREASE THE NUMBER OF AVAILABLE TRAINING POSITIONS. THERE WERE 5 GRANTS AWARDED. RECIPIENTS WERE: PARKVIEW HEALTH, BAPTIST HEALTH FLOYD, UNIVERSITY OF ILLINOIS AT CHICAGO COLLEGE OF PHARMACY AT ROCKFORD, GEISINGER MEDICAL CENTER, AND UNIVERSITY OF MARYLAND MEDICAL CENTER PHARMACY STUDENT CLINICAL SKILLS COMPETITIONMARY CASH AND SARA SCOTT, UNIVERSITY OF NORTH CAROLINA ESHELMAN SCHOOL OF PHARMACY COMPETED AGAINST OTHER TEAMS AT THE 2019 ASHP NATIONAL CLINICAL SKILLS COMPETITIONSM, HELD IN DECEMBER 2019, DURING THE ASHP MIDYEAR CLINICAL MEETING IN LAS VEGAS, NV. THE FOUNDATION HAS SPONSORED THE PHARMACY STUDENT CLINICAL SKILLS COMPETITION (CSC) AT THE ASHP MIDYEAR CLINICAL MEETING 14 YEARS. TEAMS WHO WON PRELIMINARY COMPETITIONS AT THEIR LOCAL PHARMACY SCHOOL PARTICIPATED IN THE COMPETITION. DURING THE CSC, STUDENTS DEMONSTRATE THEIR SKILLS BY ASSESSING PATIENT INFORMATION AND CURRENT THERAPY, IDENTIFYING AND PRIORITIZING DRUG THERAPY PROBLEMS, IDENTIFYING TREATMENT GOALS, AND RECOMMENDING A PHARMACIST CARE PLAN.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>666743</ExpenseAmt>
        <GrantAmt>237895</GrantAmt>
        <Desc>INNOVATIVE RESEARCH: SUPPORT HEALTH SERVICES RESEARCH THAT FOSTER INNOVATION IN PHARMACY PRACTICE, WHICH PROMOTES THE OPTIMAL, SAFE AND EFFECTIVE USE OF MEDICATION.AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION (AFPE) PRE-DOCTORAL FELLOWSHIP THE ASHP FOUNDATION PROVIDED ANNUAL FUNDING OF $7,500 FOR THE AFPE PRE-DOCTORAL FELLOWSHIP PROGRAM. PHARMACY RESIDENT PRACTICE-BASED RESEARCH GRANT PROGRAM THIS GRANT PROGRAM IS FUNDED THROUGH THE ASHP MEMBER DUES CONTRIBUTION TO THE FOUNDATION. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 8 GRANTS UP TO $5,000 EACH FOR:"CLINICAL AND ECONOMIC IMPACT OF INCORPORATING A PHARMACY TECHNICIAN INTO A MEDICATION MONITORING PROGRAM"HLEE LOR, PHARM.D KAISER PERMANENTE COLORADO, DENVER, CO "EVALUATION OF A PHARMACIST-LED OUTPATIENT ANTIBIOTIC STEWARDSHIP PROGRAM AND IMPLEMENTATION OF PRESCRIBING ORDER SETS" CURTIS BLOW, PHARM.D SUNY UPSTATE MEDICAL UNIVERSITY - UPSTATE HEALTH CARE CENTER, SYRACUSE, NY"ASSESSING THE IMPACT OF RURALBASED AMBULATORY PHARMACIST ON DIABETES CARE THROUGH PERCEPTIONS OF ADVANCED MONITORING TECHNOLOGIES" JEREMY SPARKS, PHARM.DUNIVERSITY OF FLORIDA, GAINESVILLE, FL"DEVELOPMENT AND VALIDATION OF A PHARMACIST TRANSITIONS OF CARE TOOL USING MACHINE LEARNING ALGORITHMS TO PREDICT REHOSPITALIZATION IN CHRONIC HEART FAILURE" MELISSA RIESTER, PHARM.D RHODE ISLAND HOSPITAL, PROVIDENCE, RI"DEVELOPMENT OF A NOVEL PHARMACIST-LED OPIOID DEPRESCRIBING PROTOCOL FOR OLDER ADULTS"ALISSA MARGRAF, PHARM.DRHODE ISLAND HOSPITAL/LIFESPAN PHARMACY, PROVIDENCE, RI"PHARMACIST-DRIVEN FLUID STEWARDSHIP IN THE NEUROINTENSIVE CARE"BROOKE BARLOW, PHARM.DUNIVERSITY OF KENTUCKY HEALTHCARE, LEXINGTON KY"EXPANDING SERVICES OF A PHARMACIST-LED RURAL MOBILE HEALTH CLINIC TO SCHOOL-AGED CHILDREN AND WORKING CLASS PARENTS" MEGAN STEPHAN, PHARM.DOHIO NORTHERN UNIVERSITY, ADA, OH"IMPLEMENTATION AND EVALUATION OF AN ABC INVENTORY MODEL IN A CANCER CENTER PHARMACY AT A LARGE ACADEMIC MEDICAL CENTER"ROBERT ROSE UNIVERSITY OF NORTH CAROLINA MEDICAL CENTER, CHAPEL HILL, NCPHARMACY PRACTICE ADVANCEMENT DEMONSTRATION GRANTTWELVE LETTER OF INTENT AND FULL APPLICATIONS WERE REVIEWED BY EXTERNAL REVIEW PANEL IN ORDER TO AWARD THE FY20 GRANTEES. THIS RESEARCH GRANT PROGRAM SUPPORTS DEMONSTRATION PROJECTS RELATED TO PRACTICE ADVANCEMENT, CONSISTENT WITH THE ASHP/ASHP FOUNDATION PRACTICE ADVANCEMENT INITIATIVE. GRANT FUNDS WERE PROVIDED BY THE BAXTER ENDOWMENT AND EACH GRANTEE WAS AWARDED UP TO $75,000. "IMPACT OF AN INTEGRATED PHARMACIST AND PRIMARY CARE COLLABORATIVE TRANSITIONS OF CARE PROGRAM ON CLINICAL AND ECONOMIC OUTCOMES AMONG HIGH RISK PATIENTS" INVESTIGATOR DAVID JACOBS, PHARM.D., PH.D.UNIVERSITY AT BUFFALO SCHOOL OF PHARMACY AND PHARMACEUTICAL SCIENCES, BUFFALO, NY"AN EVALUATION OF THE CLINICAL IMPACT OF PHARMACIST IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM IN A PRIMARY CARE SETTING: A PILOT STUDY"INVESTIGATOR: ARINZE NKEMDIRIM OKERE, PHARM.D.FLORIDA A&amp;M UNIVERSITY, TALLAHASSEE, FLNEW PRACTITIONER PHARMACIST LEADERSHIP DEVELOPMENT RESEARCH GRANT PROGRAM THIS NEW GRANT PROGRAM, FUNDED THROUGH THE MARIANNE F. IVEY LEADERSHIP DEVELOPMENT FUND, AWARDS NEW PRACTITIONER PHARMACISTS TO SUPPORT DIVERSE PROJECTS RELATED TO LEADERSHIP DEVELOP RESEARCH. AREAS OF FOCUS INCLUDE, MODEL DEMONSTRATION PROJECTS, SYSTEMS CHANGE PROJECTS, SPECIAL STUDIES AND EVALUATIONS THAT ARE FOCUSED ON DEVELOPING LEADERSHIP COMPETENCIES. A SIX-MEMBER EXTERNAL PEER REVIEW PANEL RECOMMENDED AWARDING 4 GRANTS UP TO $5,000 EACH FOR:"EVALUATING THE EFFECTS OF A MINDFULNESS MOBILE APPLICATION ON STUDENT PHARMACISTS' STRESS, MINDFULNESS AND BURNOUT."ANGELA CHU, PHARM.D, BCPS ROSEMAN UNIVERSITY OF HEALTH SCIENCES, HENDERSON, NV"EVALUATION OF BURNOUT AMONG PHARMACY RESIDENTS IN THE UNITED STATES."DEREK GYORI, PHARM. D., BCOP UNIVERSITY OF TOLEDO COLLEGE OF PHARMACY AND PHARMACEUTICAL SCIENCES,TOLEDO, OH"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"CHIEMENA OHANELE, PHARM.D, RPH HOWARD UNIVERSITY COLLEGE OF PHARMACY, WASHINGTON, DC"THE EFFECT OF SELF-LEADERSHIP ON BURNOUT AMONG PGY-1 PHARMACY PRACTICE RESIDENTS"STACY PASCIOLLA, PHARM.D UNIVERSITY OF THE SCIENCES, PHILADELPHIA, PARESEARCH ADVISORY COUNCIL IN FY20, THE ASHP FOUNDATION ESTABLISHED A RESEARCH ADVISORY COUNCIL TO GUIDE THE FOCUS AND EXPANSION OF OUR RESEARCH PROGRAM. THE COUNCIL MET AT ASHP HEADQUARTERS IN JANUARY 2020 AND DEVELOPED A RESEARCH AGENDA FRAMEWORK OF CORE PRINCIPLES AND PRIORITY RESEARCH AREAS THAT ALIGN WITH THE FOUNDATION'S MISSION AND ASHP'S MAJOR PRIORITIES AND ARE AT THE FOREFRONT OF THE NATIONAL HEALTHCARE AGENDA. TOOLS AND RESOURCESHARVEY A. K. WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAMTHE HARVEY A.K. WHITNEY AWARD IS THE MOST PRESTIGIOUS AWARD IN HEALTH-SYSTEM PHARMACY. THE WHITNEY AWARD LECTURES ONLINE COLLECTION PROGRAM INCLUDES A WEBSITE FOR DISSEMINATION OF WHITNEY LECTURES. THE WEBSITE PROVIDES ACCESS TO MORE THAN 60 LECTURES THAT CAN BE BROWSED BY TITLE, AUTHOR, PUBLICATION DATE OR KEYWORD. THESE LECTURES REPRESENT MORE THAN 50 YEARS OF EXCELLENCE IN PHARMACY PRACTICE, PROVIDING A UNIQUE GLIMPSE INTO OUR COLLECTIVE PAST, A COMMENTARY ON THE PRESENT, AND AN OUTLINE OF THE CHALLENGES AND OPPORTUNITIES THAT LIE AHEAD. LEADERSHIP PROGRAMSPHARMACY FORECAST REPORT 2020THE 2020 PHARMACY FORECAST REPORT WAS SUPPORTED BY A GRANT FROM OMNICELL, INC., TO THE ASHP FOUNDATION'S DAVID A. ZILZ LEADERS FOR THE FUTURE FUND AND WAS PUBLISHED IN AJHP IN THE JANUARY 15, 2020 ISSUE. THE DISTRIBUTION OF THE FORECAST REPORT IN AJHP ENSURED THAT IT WAS MADE AVAILABLE TO ALL 55,000 ASHP MEMBERS. IT WAS PUBLISHED ELECTRONICALLY IN DECEMBER 2019 AND PRESENTED AT AN EDUCATIONAL SESSION DURING THE 2019 ASHP MIDYEAR CLINICAL MEETING. THE REPORT GENERATED AUTHORITATIVE, ACTIONABLE STRATEGIC RECOMMENDATIONS TO ENHANCE THE EFFECTIVENESS OF LEADERS IN HOSPITAL AND HEALTH-SYSTEM PHARMACY. IT ALSO INCLUDED A CHAPTER ON "BLACK SWAN" EVENTS AND ITS IMPACT ON PHARMACY. VISITING LEADERS PROGRAM (VLP)THE VISITING LEADERS PROGRAM, WITH SUPPORT FROM THE DAVID A. ZILZ LEADERS FOR THE FUTURE FUND, HAD ANOTHER SUCCESSFUL YEAR. ELEVEN LEADERS WERE INVOLVED IN 14 RESIDENCY VISITS, REACHING MORE HUNDREDS OF RESIDENTS IN 14 STATES IN FY20. THE PROGRAM OFFERS AN HONORARIUM AND TRAVEL EXPENSE REIMBURSEMENT TO THE PHARMACIST LEADERS TO CONDUCT THE 2-DAY VISIT TO SELECTED RESIDENCY PROGRAMS. AN ADDITIONAL 7 VISITS WERE POSTPONED BECAUSE OF COVID19 AND WILL BE RESCHEDULED IN FY21.PHARMACY LEADERSHIP ACADEMY (PLA) THE PLA, SUPPORTED IN PART BY AN EDUCATIONAL GRANT FROM AMGEN, INC. AND APEXIS, IS AN ONLINE EDUCATION PROGRAM DESIGNED TO PROVIDE COMPREHENSIVE LEADERSHIP EDUCATION TO PHARMACISTS. THE PLA CLASS IN FY20 CONSISTED OF 100 PARTICIPANTS, WHO ALSO REMITTED TUITION AND WERE ENROLLED IN THE PROGRAM FROM JULY 2019 JUNE 2020. THE NUMBER OF GRADUATES IN BRINGS THE TOTAL NUMBER OF PLA GRADUATES TO 866 PHARMACISTS.STUDENT LEADERSHIP DEVELOPMENT WORKSHOP THE 3-HOUR LEADERSHIP DEVELOPMENT WORKSHOP FOR PHARMACY STUDENTS IS CONDUCTED ANNUALLY AT THE ASHP SUMMER MEETINGS. STATE AFFILIATES HAVE TAKEN ADVANTAGE OF THE PROGRAM TO ENGAGE STUDENTS AT THEIR ANNUAL MEETINGS. NO WORKSHOPS WERE SCHEDULED IN FY20 BECAUSE OF COVID19. LEADERSHIP SPEAKERS BUREAUA PROGRAM DESIGNED TO HAVE PHARMACY LEADERS SPEND ONE DAY WITH STUDENTS IN A LOCAL SCHOOL OF PHARMACY'S STUDENT SOCIETY OF HEALTH-SYSTEM PHARMACISTS (SSHP) TO DISCUSS EMERGING LEADERSHIP TOPICS. THE SSHP'S HAVE THE OPPORTUNITY TO SUBMIT RECEIPTS FOR REIMBURSEMENT OF UP TO $200 TO HELP COVER EXPENSES DURING THE VISIT. NO SSHP SUBMITTED EXPENSES FOR REIMBURSEMENT IN FY20. THE WILLIAM A. ZELLMER LECTURE A DISTINGUISHED SPEAKER IS INVITED TO ADDRESS THE PRACTICE LEADERS OF ASHP DURING ASHP POLICY WEEK ON AN ANNUAL BASIS. THROUGH THE LECTURE FUND, HEALTH-SYSTEM PHARMACY LEADERS FROM AROUND THE COUNTRY WILL CONTINUE TO BE INSPIRED AND CONFRONTED BY LEADING THINKERS REGARDING CONCERNS FACING PHARMACY AND HEALTHCARE. ERIN R. FOX, SENIOR DIRECTOR OF DRUG INFORMATION AND SUPPORT SERVICES AT UNIVERSITY OF UTAH HEALTH, HAS ADVICE FOR PHARMACY COLLEAGUES ABOUT HOW TO SHAPE POLICY AND DRIVE NATIONAL CONVERSATIONS ON ISSUES THAT ARE IMPORTANT TO THE PROFESSION. "THINK BIG. YOU CAN MAKE A DIFFERENCE," SHE SAID SEPT. 10 WHILE PRESENTING THE 2019 WILLIAM A. ZELLMER LECTURE IN BETHESDA, MARYLAND.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActy3Grp>
        <RevenueAmt>476790</RevenueAmt>
        <Desc>THE ASHP FOUNDATION CORPORATE PARTNERS PROGRAM IS A STRATEGIC PARTNERSHIP BETWEEN THE ASHP FOUNDATION, ASHP, AND CORPORATIONS WHICH PROMOTES MEDICATION SAFETY AND IMPROVEMENTS IN PATIENT CARE. THE PROGRAM OFFERS A ROBUST MENU OF SPONSORSHIP LEVELS AND BENEFITS FOR COMPANIES, FOCUSED ON COLLABORATION, RECOGNITION, AND INFORMATIONAL OPPORTUNITIES. THERE ARE FOUR SPONSORSHIP LEVELS AND A-LA-CARTE OPPORTUNITIES TO BETTER MEET BUSINESS OBJECTIVES. CORPORATE PARTNERS PROGRAM SPONSORSHIP IS ON AN ANNUAL BASIS. WITH THE GENEROUS SUPPORT OF CORPORATE PARTNERS, THE ASHP FOUNDATION INVESTS IN RESEARCH, AWARDS, EDUCATION, AND LEADERSHIP DEVELOPMENT THAT ADVANCES THE PHARMACY PROFESSION AND ENSURES THE SAFE, EFFECTIVE, AND OPTIMAL USE OF MEDICATIONS.</Desc>
      </ProgSrvcAccomActy3Grp>
      <TotalProgramServiceExpensesAmt>1587151</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc1039100001">1</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1234500001">1</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>0</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>0</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>0</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc1040000001">0</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc1040000001">0</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc1040000001">0</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc1040000001">0</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd>1</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc1040000001">1</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc1040000001">0</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc1040000001">0</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc1040000001">0</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc1040000001">0</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc1040000001">0</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc1040000001">1</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>0</SchoolOperatingInd>
      <ForeignOfficeInd>0</ForeignOfficeInd>
      <ForeignActivitiesInd>0</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>0</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>0</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>0</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>0</FundraisingActivitiesInd>
      <GamingActivitiesInd>0</GamingActivitiesInd>
      <OperateHospitalInd>0</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc1041900001">1</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc1041900001">1</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc1042400001">1</ScheduleJRequiredInd>
      <TaxExemptBondsInd>0</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>0</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>0</PYExcessBenefitTransInd>
      <LoanOutstandingInd>0</LoanOutstandingInd>
      <GrantToRelatedPersonInd>0</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>0</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>0</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>0</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>0</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>0</DeductibleArtContributionInd>
      <TerminateOperationsInd>0</TerminateOperationsInd>
      <PartialLiquidationInd>0</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc1043400001">0</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc1043400001">1</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>0</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc1043400001">1</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc1043400001">0</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>1</ScheduleORequiredInd>
      <IRPDocumentCnt>61</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>1</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>0</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>0</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>0</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>0</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>0</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>0</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>0</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>0</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>0</PayPremiumsPrsnlBnftCntrctInd>
      <IndoorTanningServicesInd>0</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>0</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>0</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>12</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>9</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>0</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>0</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>0</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>0</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>0</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>1</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>0</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>1</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>0</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>0</OfficerMailingAddressInd>
      <LocalChaptersInd>0</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>1</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>1</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>1</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>1</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>1</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>1</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>1</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>0</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>0</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <BusinessName>
          <BusinessNameLine1Txt>TRACY YAKLYVICH</BusinessNameLine1Txt>
        </BusinessName>
        <PhoneNum>3016648696</PhoneNum>
        <USAddress>
          <AddressLine1Txt>4500 EAST-WEST HIGHWAY SUITE 900</AddressLine1Txt>
          <CityNm>BETHESDA</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>JOHN T TIGHE III</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>R EDWARD HOWELL</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PAUL W ABRAMOWITZ</PersonNm>
        <TitleTxt>PRESIDENT/ASHP CEO</TitleTxt>
        <AverageHoursPerWeekRt>3.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>37.50</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>917893</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>54033</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>CHRISTENE JOLOWSKY</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>4.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>THOMAS J JOHNSON</PersonNm>
        <TitleTxt>TREASURER (THRU 8/19); ASHP PRESIDENT-ELECT</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>STEVEN A RUBLOFF</PersonNm>
        <TitleTxt>SECY/ASHP REF CEO</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>337637</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>45552</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROGER W ANDERSON</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MINNIE BAYLOR-HENRY</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JANET L MIGHTY</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KEN PEREZ</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>THOMAS J RICE</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SCOTT M SAMSON</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KELLY M SMITH</PersonNm>
        <TitleTxt>DIRECTOR AT LARGE</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>10150</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KATHLEEN S PAWLICKI</PersonNm>
        <TitleTxt>ASHP PRESIDENT</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>5.00</AverageHoursPerWeekRltdOrgRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>10150</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BARBARA NUSSBAUM</PersonNm>
        <TitleTxt>VP FOR RESEARCH AND EDUCATION</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>180091</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>52876</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>STEPHANIE BROWN</PersonNm>
        <TitleTxt>DIRECTOR, FOUNDATION OPERATIONS</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <AverageHoursPerWeekRltdOrgRt>0.00</AverageHoursPerWeekRltdOrgRt>
        <HighestCompensatedEmployeeInd>X</HighestCompensatedEmployeeInd>
        <ReportableCompFromOrgAmt>117258</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>22610</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>634986</TotalReportableCompFromOrgAmt>
      <TotReportableCompRltdOrgAmt>938193</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>175071</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>0</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>0</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>1</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>0</CompensationFromOtherSrcsInd>
      <CntrctRcvdGreaterThan100KCnt>0</CntrctRcvdGreaterThan100KCnt>
      <RelatedOrganizationsAmt>357100</RelatedOrganizationsAmt>
      <AllOtherContributionsAmt>570982</AllOtherContributionsAmt>
      <TotalContributionsAmt>928082</TotalContributionsAmt>
      <ProgramServiceRevenueGrp>
        <Desc>PHARMACY LEADERSHIP AC</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>605295</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>605295</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>CORPORATE PARTNER PROG</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>476790</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>476790</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>SPONSORSHIPS</Desc>
        <BusinessCd>900099</BusinessCd>
        <TotalRevenueColumnAmt>31000</TotalRevenueColumnAmt>
        <ExclusionAmt>31000</ExclusionAmt>
      </ProgramServiceRevenueGrp>
      <ProgramServiceRevenueGrp>
        <Desc>PAIN &amp; PALLIATIVE TRAI</Desc>
        <BusinessCd>611430</BusinessCd>
        <TotalRevenueColumnAmt>5500</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5500</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>1118585</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>303024</TotalRevenueColumnAmt>
        <ExclusionAmt>303024</ExclusionAmt>
      </InvestmentIncomeGrp>
      <GrossAmountSalesAssetsGrp>
        <SecuritiesAmt>593543</SecuritiesAmt>
      </GrossAmountSalesAssetsGrp>
      <LessCostOthBasisSalesExpnssGrp>
        <SecuritiesAmt>570883</SecuritiesAmt>
      </LessCostOthBasisSalesExpnssGrp>
      <GainOrLossGrp>
        <SecuritiesAmt>22660</SecuritiesAmt>
      </GainOrLossGrp>
      <NetGainOrLossInvestmentsGrp>
        <TotalRevenueColumnAmt>22660</TotalRevenueColumnAmt>
        <ExclusionAmt>22660</ExclusionAmt>
      </NetGainOrLossInvestmentsGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2372351</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>1087585</RelatedOrExemptFuncIncomeAmt>
        <UnrelatedBusinessRevenueAmt>0</UnrelatedBusinessRevenueAmt>
        <ExclusionAmt>356684</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>397535</TotalAmt>
        <ProgramServicesAmt>397535</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>35345</TotalAmt>
        <ProgramServicesAmt>35345</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>388499</TotalAmt>
        <ProgramServicesAmt>187039</ProgramServicesAmt>
        <ManagementAndGeneralAmt>28901</ManagementAndGeneralAmt>
        <FundraisingAmt>172559</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>850258</TotalAmt>
        <ProgramServicesAmt>409803</ProgramServicesAmt>
        <ManagementAndGeneralAmt>61581</ManagementAndGeneralAmt>
        <FundraisingAmt>378874</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>105393</TotalAmt>
        <ProgramServicesAmt>56955</ProgramServicesAmt>
        <ManagementAndGeneralAmt>9166</ManagementAndGeneralAmt>
        <FundraisingAmt>39272</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>86780</TotalAmt>
        <ProgramServicesAmt>39939</ProgramServicesAmt>
        <ManagementAndGeneralAmt>7600</ManagementAndGeneralAmt>
        <FundraisingAmt>39241</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>72540</TotalAmt>
        <ProgramServicesAmt>36524</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4456</ManagementAndGeneralAmt>
        <FundraisingAmt>31560</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>12500</TotalAmt>
        <ManagementAndGeneralAmt>12500</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>420434</TotalAmt>
        <ProgramServicesAmt>314350</ProgramServicesAmt>
        <ManagementAndGeneralAmt>75953</ManagementAndGeneralAmt>
        <FundraisingAmt>30131</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>52764</TotalAmt>
        <ProgramServicesAmt>45299</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6859</ManagementAndGeneralAmt>
        <FundraisingAmt>606</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>1100</TotalAmt>
        <ManagementAndGeneralAmt>1100</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <TravelGrp>
        <TotalAmt>126878</TotalAmt>
        <ProgramServicesAmt>58202</ProgramServicesAmt>
        <ManagementAndGeneralAmt>17113</ManagementAndGeneralAmt>
        <FundraisingAmt>51563</FundraisingAmt>
      </TravelGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>24496</TotalAmt>
        <ManagementAndGeneralAmt>24496</ManagementAndGeneralAmt>
      </DepreciationDepletionGrp>
      <OtherExpensesGrp>
        <Desc>GENERAL EXPENSES</Desc>
        <TotalAmt>11459</TotalAmt>
        <ProgramServicesAmt>6160</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1894</ManagementAndGeneralAmt>
        <FundraisingAmt>3405</FundraisingAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2585981</TotalAmt>
        <ProgramServicesAmt>1587151</ProgramServicesAmt>
        <ManagementAndGeneralAmt>251619</ManagementAndGeneralAmt>
        <FundraisingAmt>747211</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>81749</BOYAmt>
        <EOYAmt>160544</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>189363</BOYAmt>
        <EOYAmt>21418</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <PledgesAndGrantsReceivableGrp>
        <BOYAmt>602196</BOYAmt>
        <EOYAmt>401165</EOYAmt>
      </PledgesAndGrantsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>242712</BOYAmt>
        <EOYAmt>40644</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>283347</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipAccumDeprecAmt>97081</LandBldgEquipAccumDeprecAmt>
      <LandBldgEquipBasisNetGrp>
        <BOYAmt>11398</BOYAmt>
        <EOYAmt>186266</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <InvestmentsPubTradedSecGrp>
        <BOYAmt>8971882</BOYAmt>
        <EOYAmt>8914470</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <InvestmentsOtherSecuritiesGrp>
        <BOYAmt>161768</BOYAmt>
        <EOYAmt>125642</EOYAmt>
      </InvestmentsOtherSecuritiesGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>15018</BOYAmt>
        <EOYAmt>15018</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>10276086</BOYAmt>
        <EOYAmt>9865167</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>277949</BOYAmt>
        <EOYAmt>307673</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>576262</BOYAmt>
        <EOYAmt>557079</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>854211</BOYAmt>
        <EOYAmt>864752</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>1471468</BOYAmt>
        <EOYAmt>1506384</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>7950407</BOYAmt>
        <EOYAmt>7494031</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>9421875</BOYAmt>
        <EOYAmt>9000415</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>10276086</BOYAmt>
        <EOYAmt>9865167</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <ReconcilationRevenueExpnssAmt>-213630</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>-207830</NetUnrlzdGainsLossesInvstAmt>
      <OtherChangesInNetAssetsAmt>0</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>0</AccountantCompileOrReviewInd>
      <FSAuditedInd>1</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolAndSepBasisFinclStmtInd>X</ConsolAndSepBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>1</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>0</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc1039100001">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>2055036</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1799986</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2088349</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1768602</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>928082</CurrentTaxYearAmt>
        <TotalAmt>8640055</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>2055036</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1799986</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2088349</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1768602</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>928082</CurrentTaxYearAmt>
        <TotalAmt>8640055</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>3945100</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>4694955</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>294198</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>270016</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>315175</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>406338</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>303024</CurrentTaxYearAmt>
        <TotalAmt>1588751</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <TotalSupportAmt>10228806</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>3442131</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.45900</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.47510</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1234500001">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc1040000001">
      <CYEndwmtFundGrp>
        <BeginningYearBalanceAmt>6808429</BeginningYearBalanceAmt>
        <ContributionsAmt>1300</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>106680</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>185232</OtherExpendituresAmt>
        <EndYearBalanceAmt>6731177</EndYearBalanceAmt>
      </CYEndwmtFundGrp>
      <CYMinus1YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6838821</BeginningYearBalanceAmt>
        <ContributionsAmt>1480</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>93478</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>125350</OtherExpendituresAmt>
        <EndYearBalanceAmt>6808429</EndYearBalanceAmt>
      </CYMinus1YrEndwmtFundGrp>
      <CYMinus2YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6732965</BeginningYearBalanceAmt>
        <ContributionsAmt>6019</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>423554</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>323717</OtherExpendituresAmt>
        <EndYearBalanceAmt>6838821</EndYearBalanceAmt>
      </CYMinus2YrEndwmtFundGrp>
      <CYMinus3YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6264149</BeginningYearBalanceAmt>
        <ContributionsAmt>291302</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>654392</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>476878</OtherExpendituresAmt>
        <EndYearBalanceAmt>6732965</EndYearBalanceAmt>
      </CYMinus3YrEndwmtFundGrp>
      <CYMinus4YrEndwmtFundGrp>
        <BeginningYearBalanceAmt>6403208</BeginningYearBalanceAmt>
        <ContributionsAmt>1700</ContributionsAmt>
        <InvestmentEarningsOrLossesAmt>-65917</InvestmentEarningsOrLossesAmt>
        <OtherExpendituresAmt>74842</OtherExpendituresAmt>
        <EndYearBalanceAmt>6264149</EndYearBalanceAmt>
      </CYMinus4YrEndwmtFundGrp>
      <BoardDesignatedBalanceEOYPct>0.07430</BoardDesignatedBalanceEOYPct>
      <PrmnntEndowmentBalanceEOYPct>0.75660</PrmnntEndowmentBalanceEOYPct>
      <TermEndowmentBalanceEOYPct>0.16910</TermEndowmentBalanceEOYPct>
      <EndowmentsHeldUnrelatedOrgInd>0</EndowmentsHeldUnrelatedOrgInd>
      <EndowmentsHeldRelatedOrgInd>0</EndowmentsHeldRelatedOrgInd>
      <EquipmentGrp>
        <OtherCostOrOtherBasisAmt>83984</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>77145</DepreciationAmt>
        <BookValueAmt>6839</BookValueAmt>
      </EquipmentGrp>
      <OtherLandBuildingsGrp>
        <OtherCostOrOtherBasisAmt>199363</OtherCostOrOtherBasisAmt>
        <DepreciationAmt>19936</DepreciationAmt>
        <BookValueAmt>179427</BookValueAmt>
      </OtherLandBuildingsGrp>
      <TotalBookValueLandBuildingsAmt>186266</TotalBookValueLandBuildingsAmt>
      <TotalRevEtcAuditedFinclStmtAmt>2411124</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>-207830</NetUnrealizedGainsInvstAmt>
      <DonatedServicesAndUseFcltsAmt>246603</DonatedServicesAndUseFcltsAmt>
      <RevenueNotReportedAmt>38773</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>2372351</RevenueSubtotalAmt>
      <RevenueNotReportedFinclStmtAmt>0</RevenueNotReportedFinclStmtAmt>
      <TotalRevenuePerForm990Amt>2372351</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2832584</TotExpnsEtcAuditedFinclStmtAmt>
      <DonatedServicesUseFcltsAmt>246603</DonatedServicesUseFcltsAmt>
      <ExpensesNotReportedAmt>246603</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>2585981</ExpensesSubtotalAmt>
      <ExpensesNotRptFinclStmtAmt>0</ExpensesNotRptFinclStmtAmt>
      <TotalExpensesPerForm990Amt>2585981</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART V, LINE 4:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S ENDOWMENT PRIMARILY CONSISTS OF CONTRIBUTIONS TO THE JOSEPH A. ODDIS ENDOWMENT CAMPAIGN, THE PURPOSE OF WHICH IS TO RAISE FUNDS FOR PROGRAMS THAT IMPROVE PHARMACY PRACTICE AND THE SAFE AND EFFECTIVE USE OF MEDICATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleI documentId="RetDoc1041900001">
      <GrantRecordsMaintainedInd>1</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>AMERICAN FOUNDATION FOR PHARMACEUTICAL EDUCATION</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>ONE CHURCH STREET</AddressLine1Txt>
          <CityNm>ROCKVILLE</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20850</ZIPCd>
        </USAddress>
        <RecipientEIN>530214882</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>7500</CashGrantAmt>
        <PurposeOfGrantTxt>2019 SPONSORSHIP</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISITS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>4500 EAST-WEST HIGHWAY</AddressLine1Txt>
          <CityNm>BETHESDA</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
        <RecipientEIN>520807628</RecipientEIN>
        <IRCSectionDesc>501(C)6</IRCSectionDesc>
        <CashGrantAmt>34640</CashGrantAmt>
        <PurposeOfGrantTxt>CLINICAL SKILLS COMPETITION</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>EDWARD VIA VIRGINIA COLLEGE OF OSTEOPATHIC MEDICINE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2265 KRAFT DRIVE</AddressLine1Txt>
          <CityNm>BLACKSBURG</CityNm>
          <StateAbbreviationCd>VA</StateAbbreviationCd>
          <ZIPCd>24060</ZIPCd>
        </USAddress>
        <RecipientEIN>542052107</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>6800</CashGrantAmt>
        <PurposeOfGrantTxt>NEW INVESTIGATOR RESEARCH GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>109 KINKEAD HALL</AddressLine1Txt>
          <CityNm>LEXINGTON</CityNm>
          <StateAbbreviationCd>KY</StateAbbreviationCd>
          <ZIPCd>40506</ZIPCd>
        </USAddress>
        <RecipientEIN>616033693</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>6611</CashGrantAmt>
        <PurposeOfGrantTxt>NEW INVESTIGATOR RESEARCH GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PURDUE UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1281 WIN HENTSCHEL BLVD</AddressLine1Txt>
          <CityNm>WEST LAFAYETTE</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>47906</ZIPCd>
        </USAddress>
        <RecipientEIN>356002041</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25388</CashGrantAmt>
        <PurposeOfGrantTxt>2016 PHARMACY PRACTICE MODEL GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>DENT NEUROSCIENCES RESEARCH CENTER INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>3980 SHERIDAN DRIVE SUITE 500</AddressLine1Txt>
          <CityNm>AMHERST</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>14226</ZIPCd>
        </USAddress>
        <RecipientEIN>161583617</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>23382</CashGrantAmt>
        <PurposeOfGrantTxt>2019 PRACTICE ADVANCEMENT DEMO GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF TENNESSEE</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>201 ANDY HOLT TOWER</AddressLine1Txt>
          <CityNm>KNOXVILLE</CityNm>
          <StateAbbreviationCd>TN</StateAbbreviationCd>
          <ZIPCd>37996</ZIPCd>
        </USAddress>
        <RecipientEIN>626001636</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>24750</CashGrantAmt>
        <PurposeOfGrantTxt>2019 PRACTICE ADVANCEMENT DEMO GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>PO BOX 9</AddressLine1Txt>
          <CityNm>ALBANY</CityNm>
          <StateAbbreviationCd>NY</StateAbbreviationCd>
          <ZIPCd>12201</ZIPCd>
        </USAddress>
        <RecipientEIN>141368361</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>24750</CashGrantAmt>
        <PurposeOfGrantTxt>2019 PRACTICE ADVANCEMENT DEMO GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>FLORIDA A&amp;M UNIVERSITY</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1700 LEE HALL DRIVE</AddressLine1Txt>
          <CityNm>TALLAHASSEE</CityNm>
          <StateAbbreviationCd>FL</StateAbbreviationCd>
          <ZIPCd>32307</ZIPCd>
        </USAddress>
        <RecipientEIN>590977035</RecipientEIN>
        <IRCSectionDesc>STATE AGENCY</IRCSectionDesc>
        <CashGrantAmt>24750</CashGrantAmt>
        <PurposeOfGrantTxt>2019 PRACTICE ADVANCEMENT DEMO GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>GEISINGER MEDICAL CENTER</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>100 NORTH ACADEMY AVENUE</AddressLine1Txt>
          <CityNm>DANVILLE</CityNm>
          <StateAbbreviationCd>PA</StateAbbreviationCd>
          <ZIPCd>17822</ZIPCd>
        </USAddress>
        <RecipientEIN>240795959</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>RESIDENCY EXPANSION GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>506 S WRIGHT STREET</AddressLine1Txt>
          <CityNm>URBANA</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>61801</ZIPCd>
        </USAddress>
        <RecipientEIN>376000511</RecipientEIN>
        <IRCSectionDesc>STATE AGENCY</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>RESIDENCY EXPANSION GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>PARKVIEW HOSPITAL INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>11109 PARKVIEW PLAZA DRIVE</AddressLine1Txt>
          <CityNm>FORT WAYNE</CityNm>
          <StateAbbreviationCd>IN</StateAbbreviationCd>
          <ZIPCd>46845</ZIPCd>
        </USAddress>
        <RecipientEIN>350868085</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>RESIDENCY EXPANSION GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF MARYLAND MEDICAL SYSTEM CORPORATION</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>22 SOUTH GREENE STREET</AddressLine1Txt>
          <CityNm>BALTIMORE</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>21201</ZIPCd>
        </USAddress>
        <RecipientEIN>521362793</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>RESIDENCY EXPANSION GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>BAPTIST HEALTHCARE SYSTEM INC</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>2701 EASTPOINT PARKWAY</AddressLine1Txt>
          <CityNm>LOUISVILLE</CityNm>
          <StateAbbreviationCd>KY</StateAbbreviationCd>
          <ZIPCd>40223</ZIPCd>
        </USAddress>
        <RecipientEIN>610444707</RecipientEIN>
        <IRCSectionDesc>501(C)3</IRCSectionDesc>
        <CashGrantAmt>25000</CashGrantAmt>
        <PurposeOfGrantTxt>RESIDENCY EXPANSION GRANT</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>13</Total501c3OrgCnt>
      <TotalOtherOrgCnt>1</TotalOtherOrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>LITERATURE AWARD</GrantTypeTxt>
        <RecipientCnt>8</RecipientCnt>
        <CashGrantAmt>17345</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>STUDENT LEADERSHIP AWARDS</GrantTypeTxt>
        <RecipientCnt>9</RecipientCnt>
        <CashGrantAmt>18000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 2:</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ASHP FOUNDATION HAS A DETAILED REPORTING REQUIREMENT FOR ALL GRANTS AWARDED WHICH INCLUDES REPORTING PROGRESS AT 6-MONTH INTERVALS. ANY UNUSED GRANT FUNDS MUST BE RETURNED. THE ASHP FOUNDATION HAS A GOOD TRACK RECORD OF ENSURING STUDY COMPLETION AND PUBLICATION OF STUDY RESULTS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc1042400001">
      <SeverancePaymentInd>0</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>0</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>0</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>0</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>0</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>1</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>1</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>1</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>0</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>PAUL W ABRAMOWITZ</PersonNm>
        <TitleTxt>PRESIDENT/ASHP CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>0</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>771153</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>0</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>115500</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>0</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>31240</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>0</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>27700</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>0</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>31162</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>0</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>976755</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>STEVEN A RUBLOFF</PersonNm>
        <TitleTxt>SECY/ASHP REF CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>311395</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>25000</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>1242</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>11200</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>39662</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>388499</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>BARBARA NUSSBAUM</PersonNm>
        <TitleTxt>VP FOR RESEARCH AND EDUCATION</TitleTxt>
        <BaseCompensationFilingOrgAmt>171234</BaseCompensationFilingOrgAmt>
        <CompensationBasedOnRltdOrgsAmt>0</CompensationBasedOnRltdOrgsAmt>
        <BonusFilingOrganizationAmount>7875</BonusFilingOrganizationAmount>
        <BonusRelatedOrganizationsAmt>0</BonusRelatedOrganizationsAmt>
        <OtherCompensationFilingOrgAmt>982</OtherCompensationFilingOrgAmt>
        <OtherCompensationRltdOrgsAmt>0</OtherCompensationRltdOrgsAmt>
        <DeferredCompensationFlngOrgAmt>18524</DeferredCompensationFlngOrgAmt>
        <DeferredCompRltdOrgsAmt>0</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsFilingOrgAmt>40181</NontaxableBenefitsFilingOrgAmt>
        <NontaxableBenefitsRltdOrgsAmt>0</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationFilingOrgAmt>238796</TotalCompensationFilingOrgAmt>
        <TotalCompensationRltdOrgsAmt>0</TotalCompensationRltdOrgsAmt>
        <CompReportPrior990FilingOrgAmt>0</CompReportPrior990FilingOrgAmt>
        <CompReportPrior990RltdOrgsAmt>0</CompReportPrior990RltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED ORGANIZATION, USES THE FOLLOWING TO ESTABLISH COMPENSATION OF ITS CEO: COMPENSATION COMMITTEE, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, FORM 990 OF OTHER ORGANIZATIONS, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 6</FormAndLineReferenceDesc>
        <ExplanationTxt>PAUL ABRAMOWITZ, PRESIDENT/ASHP CEO, AND STEVEN RUBLOFF SECRETARY/ASHP REF CEO, RECEIVE A BONUS BASED ON THE ACHIEVEMENT OF SPECIFIC FINANCIAL AND NON-FINANCIAL OUTCOMES FOR THEIR RESPECTIVE ORGANIZATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>PART I, LINE 7</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL ASHP-REF EMPLOYEES ARE ELIGIBLE FOR AN ANNUAL PERFORMANCE INCENTIVE PROGRAM IN ACCORDANCE WITH POLICY, AT THE DISCRETION OF THE BOARD OF DIRECTORS, BASED ON MUTUALLY AGREED UPON PREDETERMINED OBJECTIVES.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc1044400001">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 7A</FormAndLineReferenceDesc>
        <ExplanationTxt>THREE MANDATORY MEMBERS OF THE FOUNDATION'S BOARD OF DIRECTORS ARE: THE IMMEDIATE PAST PRESIDENT, CEO, AND TREASURER OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS, A RELATED 501(C)(6) MEMBERSHIP ORGANIZATION. THE AFOREMENTIONED TREASURER AND CEO SHALL SERVE, RESPECTIVELY, AS THE TREASURER AND PRESIDENT OF THE FOUNDATION, AND THE IMMEDIATE PAST PRESIDENT SHALL SERVE AS A DIRECTOR OF THE FOUNDATION. THE BOARD OF DIRECTORS OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS MAY ALSO APPOINT ONE OR MORE MEMBERS OF THE PUBLIC TO SERVE AS MEMBERS OF THE FOUNDATION'S BOARD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION A, LINE 8B</FormAndLineReferenceDesc>
        <ExplanationTxt>THERE ARE NO COMMITTEES THAT HAVE THE AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FORM 990 IS REVIEWED BY THE CHIEF OPERATIONS AND FINANCIAL OFFICERS AND BY THE BOARD BEFORE IT IS FILED. EACH MEMBER HAS THE OPPORTUNITY TO REVIEW THE FORM 990.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE CONFLICT OF INTEREST POLICY WILL BE REVIEWED ANNUALLY AT THE SPRING OR FALL MEETING</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION B, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>CEO, EXECUTIVE DIRECTOR OR TOP MANAGEMENT: A "CEO EVALUATION SUBCOMMITTEE" IS APPOINTED BY THE BOARD AND MEETS SEVERAL TIMES ON AN ANNUAL BASIS. THIS SUBCOMMITTEE IS RESPONSIBLE FOR EVALUATING CEO PERFORMANCE ANNUALLY AND NEGOTIATING A CONTRACT THAT CUSTOMARILY SPANS A 3-YEAR PERIOD. THE TREASURER CHAIRS THE SUBCOMMITTEE DURING THE CONTRACT RENEGOTIATION YEAR AND THE BOARD CHAIR LEADS THE SUBCOMMITTEE DURING NON-CONTRACT YEAR ANNUAL REVIEWS. ALL SUBCOMMITTEE ACTIONS ARE REVIEWED BY THE FULL BOARD PRIOR TO TAKING ANY ACTIONS. ONE FULL YEAR PRIOR TO THE COMPLETION OF A CONTRACT CYCLE, THE SUBCOMMITTEE MAKES A REFLECTIVE REVIEW OF PERFORMANCE DURING THE CONTRACT PERIOD. ADDITIONALLY, A CEO SELF-ASSESSMENT IS COMPLETED AND REVIEWED BY THE SUBCOMMITTEE. THE REFLECTIVE PERFORMANCE REVIEW AND SELF-ASSESSMENT IS CONSIDERED BY THE BOARD AND A DECISION IS MADE AS TO WHETHER THE BOARD DESIRES TO RENEGOTIATE A NEW CONTRACT WITH THE EXISTING CEO OR SEEK A REPLACEMENT. IF A REPLACEMENT IS DESIRED, THEN A SEARCH COMMITTEE IS APPOINTED. IF CONTRACT RENEGOTIATION WITH THE CURRENT CEO IS DESIRED, THE CEO EVALUATION COMMITTEE LEADS CONTRACT RENEGOTIATIONS UNDER THE LEADERSHIP OF THE TREASURER. A CONTRACT FOR THE BOARD'S CONSIDERATION IS ESTABLISHED IN WRITING WITH ALL PROVISIONS OUTLINED, INCLUDING COMPENSATION AND BENEFITS. TO DETERMINE PROPOSED COMPENSATION THE SUBCOMMITTEE REVIEWS 1) NATIONAL SURVEY DATA FOR THE CEO POSITION; 2) THE AMERICAN SOCIETY OF ASSOCIATION EXECUTIVE (ASAE) COMPENSATION DATA FOR EXECUTIVES IS REVIEWED FOCUSING ON SIMILAR/COMPETITIVE HEALTHCARE ORGANIZATIONS IN THE MID-ATLANTIC REGION; AND 3) GUIDESTAR'S DATABASE IS REFERENCED TO IDENTIFY CEO COMPENSATION IN COMPETITIVE ORGANIZATION'S 990 FILINGS. ULTIMATELY, A NEW CONTRACT IS PRESENTED TO THE BOARD FOR APPROVAL THAT OUTLINES COMPENSATION AND PERFORMANCE EXPECTATIONS. IN NON-CONTRACT RENEWAL YEARS, THE SUBCOMMITTEE COMPLETES A DRAFT ANNUAL PERFORMANCE REVIEW FOR THE BOARD'S CONSIDERATION PRIOR TO CONDUCTING THE ANNUAL PERFORMANCE REVIEW ALONG WITH A SET OF CEO PERFORMANCE OBJECTIVES FOR THE UPCOMING YEAR AND A CEO SELF-ASSESSMENT SUMMARY. IN ALL CASES CEO PERFORMANCE IS MEASURED AGAINST BOARD-APPROVED ANNUAL PERFORMANCE OBJECTIVES. OTHER OFFICERS OR KEY EMPLOYEES: THE CEO DETERMINES COMPENSATION FOR KEY EMPLOYEES RELYING HEAVILY UPON THE GUIDANCE OF THE HUMAN RESOURCES DEPARTMENT OF ASHP. ASAE SURVEY DATA IS REVIEWED WHEN COMPARABLE POSITIONS EXIST FOR THE KEY EMPLOYEE POSITION (E.G. DIRECTOR OF COMMUNICATIONS). THE HUMAN RESOURCES DEPARTMENT UTILIZES ADDITIONAL SALARY SURVEY DATABASES TO COMPARE SALARIES. FOR POSITIONS WHERE A PHARMACIST IS A JOB REQUIREMENT, PHARMACIST POSITIONS IN HOSPITALS AND HEALTH-SYSTEMS THAT WOULD BE LIKELY CANDIDATE POOLS ARE QUERIED IN THE SALARY SURVEY DATABASES. ADDITIONALLY, THE HR DEPARTMENT CAN PROVIDE COMPARATIVE DATA FOR PHARMACIST POSITIONS AT ASHP.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VI, SECTION C, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE FOUNDATION'S FINANCIAL STATEMENTS, GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>CONTRACT SERVICES: PROGRAM SERVICE EXPENSES 314,350. MANAGEMENT AND GENERAL EXPENSES 75,953. FUNDRAISING EXPENSES 30,131. TOTAL EXPENSES 420,434.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc1043400001">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS (ASHP)</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>4500 EAST-WEST HIGHWAY SUITE 900</AddressLine1Txt>
          <CityNm>BETHESDA</CityNm>
          <StateAbbreviationCd>MD</StateAbbreviationCd>
          <ZIPCd>20814</ZIPCd>
        </USAddress>
        <EIN>520807628</EIN>
        <PrimaryActivitiesTxt>TO ADVANCE PUBLIC HEALTH BY SUPPORTING THE PHARMACY PROFESSION</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MD</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>501(C)(6)</ExemptCodeSectionTxt>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <ControlledOrganizationInd>0</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>0</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>1</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>1</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>0</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>0</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>0</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>0</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>0</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>0</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>0</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>0</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>0</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>0</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>1</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>1</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>1</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>0</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>0</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>1</TransferFromOtherOrgInd>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>C</TransactionTypeTxt>
        <InvolvedAmt>357100</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>N</TransactionTypeTxt>
        <InvolvedAmt>509291</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>RECORDED EXPENSES</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>O</TransactionTypeTxt>
        <InvolvedAmt>180698</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>FAIR VALUE</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>P</TransactionTypeTxt>
        <InvolvedAmt>1704011</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>RECORDED EXPENSES</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
      <TransactionsRelatedOrgGrp>
        <OtherOrganizationName>
          <BusinessNameLine1Txt>AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS</BusinessNameLine1Txt>
        </OtherOrganizationName>
        <TransactionTypeTxt>S</TransactionTypeTxt>
        <InvolvedAmt>1194721</InvolvedAmt>
        <MethodOfAmountDeterminationTxt>CASH</MethodOfAmountDeterminationTxt>
      </TransactionsRelatedOrgGrp>
    </IRS990ScheduleR>
  </ReturnData>
</Return>